CN1871362A - 卵巢癌的诊断标记物 - Google Patents

卵巢癌的诊断标记物 Download PDF

Info

Publication number
CN1871362A
CN1871362A CNA200480030838XA CN200480030838A CN1871362A CN 1871362 A CN1871362 A CN 1871362A CN A200480030838X A CNA200480030838X A CN A200480030838XA CN 200480030838 A CN200480030838 A CN 200480030838A CN 1871362 A CN1871362 A CN 1871362A
Authority
CN
China
Prior art keywords
haptoglobin
ovarian cancer
precursor
serum
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200480030838XA
Other languages
English (en)
Chinese (zh)
Inventor
N·阿梅德
G·E·赖斯
M·A·奎因
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Womens Hospital
Original Assignee
Royal Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2003904844A external-priority patent/AU2003904844A0/en
Application filed by Royal Womens Hospital filed Critical Royal Womens Hospital
Publication of CN1871362A publication Critical patent/CN1871362A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CNA200480030838XA 2003-09-05 2004-09-06 卵巢癌的诊断标记物 Pending CN1871362A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003904844 2003-09-05
AU2003904844A AU2003904844A0 (en) 2003-09-05 Diagnostic marker

Publications (1)

Publication Number Publication Date
CN1871362A true CN1871362A (zh) 2006-11-29

Family

ID=34230078

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200480030838XA Pending CN1871362A (zh) 2003-09-05 2004-09-06 卵巢癌的诊断标记物

Country Status (6)

Country Link
US (1) US20070053896A1 (enExample)
EP (1) EP1668149A4 (enExample)
JP (1) JP2007504463A (enExample)
CN (1) CN1871362A (enExample)
CA (1) CA2537955A1 (enExample)
WO (1) WO2005024054A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102686612A (zh) * 2009-09-29 2012-09-19 赛托盖德公司 靶向cd163受体的偶联物
CN104225619A (zh) * 2013-06-09 2014-12-24 上海金鉴生物科技有限公司 人ilk基因治疗肿瘤的用途及其相关药物
CN106520924A (zh) * 2016-10-14 2017-03-22 浙江大学 一种用于检测卵巢癌的引物组及检测方法
CN106544421A (zh) * 2016-10-21 2017-03-29 武汉科技大学 Spag6基因作为卵巢肿瘤诊断和治疗标志物的用途

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
CN101243319B (zh) 2005-06-22 2016-01-06 约翰·霍普金斯大学 卵巢癌的生物标记：ctap3-相关蛋白质
JP5237817B2 (ja) * 2005-10-21 2013-07-17 ジーンニュース インコーポレーティッド バイオマーカー産物レベルを疾患に相関させるための方法および装置
EP2363205A3 (en) 2006-01-11 2014-06-04 Raindance Technologies, Inc. Microfluidic Devices And Methods Of Use In The Formation And Control Of Nanoreactors
EP1987360B1 (en) * 2006-01-27 2012-03-07 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2530168B1 (en) 2006-05-11 2015-09-16 Raindance Technologies, Inc. Microfluidic Devices
EP2077912B1 (en) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
SG140505A1 (en) * 2006-09-05 2008-03-28 Univ Singapore Diagnostic biomolecule(s)
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
JP5422785B2 (ja) * 2008-09-12 2014-02-19 国立大学法人名古屋大学 質量分析法を利用した複数癌腫の血液検出のための方法および生物マーカー
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
EP2517025B1 (en) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Methods for reducing the exchange of molecules between droplets
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
JP5934657B2 (ja) 2010-02-12 2016-06-15 レインダンス テクノロジーズ， インコーポレイテッド デジタル検体分析
WO2011143292A1 (en) * 2010-05-11 2011-11-17 Ohio University Biomarkers for detecting erythropoietin use in human subjects
KR101313184B1 (ko) * 2010-06-24 2013-09-30 한국표준과학연구원 질병 지표 검출 키트 및 질병 지표 검출 방법
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
EP3859011A1 (en) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
EP2675819B1 (en) 2011-02-18 2020-04-08 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
DE202012013668U1 (de) 2011-06-02 2019-04-18 Raindance Technologies, Inc. Enzymquantifizierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
WO2012174569A2 (en) * 2011-06-17 2012-12-20 The Board Of Trustees Of The University Of Arkansas New markers for early diagnosis of ovarian cancer, monitoring during therapy, and new therapy options during and after chematherapy
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
EP2844768B1 (en) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digital analyte analysis
EP2986762B1 (en) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
KR101582416B1 (ko) * 2014-06-30 2016-01-06 가톨릭대학교 산학협력단 프로합토글로빈을 이용한 간암 진단방법
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
AU2017244763A1 (en) * 2016-03-29 2018-10-18 Kyowa Kirin Co., Ltd. Autoimmune disease therapeutic agent containing, as active ingredient, antibody that binds to haptoglobin in blood to form polyvalent immune complex
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN114324557B (zh) * 2021-12-03 2024-05-10 融智生物科技（青岛）有限公司 一种基于MALDI-TOF MS的ζ-珠蛋白的检测方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946774A (en) * 1987-11-09 1990-08-07 Trustees Of Boston University Process for detecting cancer and for monitoring the effectiveness of cancer therapy
KR0174528B1 (ko) * 1989-01-17 1999-05-15 마이클 이. 존스 암과 관련된 헵토글로빈
GB9805477D0 (en) * 1998-03-13 1998-05-13 Oxford Glycosciences Limited Methods and compositions for diagnosis of rheumatoid arthritis
US7112408B2 (en) * 2001-06-08 2006-09-26 The Brigham And Women's Hospital, Inc. Detection of ovarian cancer based upon alpha-haptoglobin levels
AU2002335963A1 (en) * 2001-11-23 2003-06-10 Syn.X Pharma, Inc. Protein biopolymer markers predictive of alzheimers disease
AU2003235749A1 (en) * 2002-01-07 2003-07-24 John Hopkins University Biomarkers for detecting ovarian cancer

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102686612A (zh) * 2009-09-29 2012-09-19 赛托盖德公司 靶向cd163受体的偶联物
CN102686612B (zh) * 2009-09-29 2019-01-01 艾芬尼康有限公司 靶向cd163受体的偶联物
CN104225619A (zh) * 2013-06-09 2014-12-24 上海金鉴生物科技有限公司 人ilk基因治疗肿瘤的用途及其相关药物
CN106520924A (zh) * 2016-10-14 2017-03-22 浙江大学 一种用于检测卵巢癌的引物组及检测方法
CN106544421A (zh) * 2016-10-21 2017-03-29 武汉科技大学 Spag6基因作为卵巢肿瘤诊断和治疗标志物的用途
CN106544421B (zh) * 2016-10-21 2020-05-08 武汉科技大学 Spag6基因作为卵巢肿瘤诊断和治疗标志物的用途

Also Published As

Publication number Publication date
EP1668149A4 (en) 2007-01-03
JP2007504463A (ja) 2007-03-01
WO2005024054A1 (en) 2005-03-17
CA2537955A1 (en) 2005-03-17
US20070053896A1 (en) 2007-03-08
EP1668149A1 (en) 2006-06-14

Similar Documents

Publication Publication Date Title
US20070053896A1 (en) Diagnostic marker for ovarian cancer
Ahmed et al. Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer
KR100846354B1 (ko) 혈청 당단백질부터 분리한 폐암 진단용 마커
CN103547923B (zh) 乳腺癌的生物标记
US10345309B2 (en) Biomarkers for gastric cancer and uses thereof
Yang et al. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases
WO2011035433A1 (en) Selected strains on serum-free growth media for proteomics analysis of lung cancer biomarkers
EP2369349A2 (en) Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
AU2006304605A1 (en) Tissue-and serum-derived glycoproteins and methods of their use
AU2015360694A1 (en) Use of markers including filamin a in the diagnosis and treatment of prostate cancer
WO2010015659A1 (en) Cancer markers and methods for their detection
US8642347B2 (en) Urinary CA125 peptides as biomarkers of ovarian cancer
JP4515099B2 (ja) Ｌａｓｐ−１免疫反応性の決定によって炎症性疾患および感染を診断するための方法
ES2896056T3 (es) PD-ECGF como biomarcador de cáncer
US20080108549A1 (en) Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia
AU2004270759A1 (en) Diagnostic marker for ovarian cancer
KR20160113418A (ko) 자궁내막증 진단용 조성물 및 이를 포함하는 진단키트
WO2005003768A1 (en) Protein markers for human benign prostatic hyperplasia (bph)
CA3214833A1 (en) Protein markers for the prognosis of breast cancer progression
WO2010145000A1 (en) Biomarker of sarcomas
WO2004005536A1 (en) Nephrotoxicity marker fumarylacetoacetase
HK1206414B (en) Biomarkers for gastric cancer and uses thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication